Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years
In 2018, the Food and Drug Administration expanded the age of eligibility for the human papillomavirus (HPV) vaccine to 27 to 45 years. However, it is unclear if there are racial/ethnic disparities in HPV vaccine uptake for this age-group following this expanded recommendation. We aimed to identify...
Saved in:
| Main Authors: | Natalie L. Rincon, Kelsey Rae McDowell, Darien Weatherspoon, Tiarney D. Ritchwood, Daniel J. Rocke, Eric Adjei Boakye, Nosayaba Osazuwa-Peters |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2313249 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overcoming Barriers to Human Papillomavirus Vaccination in Guangdong Province, China
by: Shuaijing Zhang, et al.
Published: (2025-04-01) -
Human papillomavirus (HPV) vaccination in a privately funded program in Ghana: A qualitative case study
by: Emmanuel Marfo, et al.
Published: (2024-12-01) -
Dental hygienists' practices and perceptions towards human papillomavirus vaccination: A cross-sectional study in California
by: Vinodh Bhoopathi, et al.
Published: (2025-07-01) -
HPV prevalence and genotype distribution among women in Sanming, China: a retrospective analysis before large-scale vaccination
by: Xiang Jiang, et al.
Published: (2025-07-01) -
A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs
by: Marisa Felsher, et al.
Published: (2024-12-01)